摘要
2013年美国心脏病学学会/美国心脏协会血脂指南的发布在学界激起波澜,国内外众多学术组织相继发布文件阐明自己的观点。2016年,欧洲心脏病协会和中国血脂指南相继发表。3个指南在血脂管理上存在诸多不同,争论的焦点在于是否设立降脂靶目标以及如何强化,差异之处体现了各自对于血脂的独特理解。本文从这两点出发进行探讨。
The release of ＂2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce athero- sclerotic cardiovascular risk in adults＂ aroused wide controversy. In 2016, ＂ESC Guidelines for the Management of Dyslipidaemias＂ and ＂Chinese guideline for the management of dyslipidemia in adults＂ were published. There were some inconsistencies among the recommendations of ACC/AHA, ESC and Chinese Guidelines. The focuses of the debates are whether to set the lipid-lowering target and how to strengthen lipid-lowering. Exploring the differences among them is helpful to deepen our understanding of dyslipidemia management. This paper attempts to discuss those current controversial hot issues.
出处
《临床心血管病杂志》
CAS
CSCD
北大核心
2017年第6期511-513,共3页
Journal of Clinical Cardiology
关键词
血脂异常
指南
dyslipidemia
guideline
